External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home IMS 2023
Roche and Genentech at

IMS 2023

September 27 - September 30
Athens, Greece / Virtual (Hybrid)
www.myelomasociety.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
04:30 PM
Duration 60mins Skalkotas
Efficacy of forimtamig, a GPRC5DxCD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: analysis of patient- and disease-related factors associated with responses
Simon J Harrison, Caroline Hasselbalch Riley, Salomon Manier, Sung-Soo Yoon, Antonio Pinto, Titouan Cazaubiel, Anna Guidetti, Rakesh Popat, Cyrille Touzeau, Enrique M Ocio, Fritz Offner, Paula Rodriguez Otero, Ilaria Rizzello, Maria-Victoria Mateos, Ann-Marie E Broske, Iryna Dekhtiarenko, Natalie Dimier, Jan Eckmann, Hans-Joachim Helms, Wolfgang Jacob, Meike Schneider, Nassim Sleiman, Martin Weisser, Carmelo Carlo-Stella
Haematology | Multiple Myeloma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.